Over the years, ECOG has conducted numerous groundbreaking clinical trials that have significantly advanced the field of oncology. Some notable trials include:
ECOG-ACRIN E2100: A trial that demonstrated the efficacy of combining bevacizumab with paclitaxel for metastatic breast cancer. ECOG E4400: A trial that investigated the use of cetuximab in combination with chemotherapy for advanced colorectal cancer. ECOG E1500: A trial that explored the benefits of high-dose chemotherapy followed by autologous stem cell transplantation for patients with multiple myeloma.